Variant Synonymizer: Platform to identify mutations defined in different ways is available now!
Over 2,000 gene–disease validation summaries are now available—no login required!
TRPV6 encodes a highly selective epithelial calcium channel critical for Ca²⁺ entry in multiple tissues. Recent NGS studies re-screening idiopathic pancreatitis cohorts for novel risk genes identified TRPV6 variants in 7.3% of patients, implicating it in pancreatic disease susceptibility (PMID:38657903).
Case–control sequencing in Japan found function-affecting TRPV6 variants in 13 of 300 patients with nonalcoholic chronic pancreatitis (4.3%) versus 1 of 1070 controls (0.1%; OR 48.4) (PMID:31930989). Early-onset cohorts (≤20 y) revealed 12 of 124 patients (9.7%) carrying such variants, and European replication demonstrated 18 of ∼880 patients (2.0%) versus 0 controls (PMID:31930989). A Chinese sequencing study further showed an enrichment of loss-of-function alleles in 9 of 669 patients (1.35%) versus 1 of 609 controls (0.16%; OR 8.29) (PMID:32383311).
Independent European cohorts from Poland and Germany confirmed overrepresentation of TRPV6 nonsense and deleterious missense variants (p.Arg174Ter, p.Arg342Gln, p.Leu576Arg) in early-onset chronic pancreatitis, with functional assays in HEK293T cells demonstrating significantly reduced intracellular Ca²⁺ levels (PMID:34538581).
Mechanistically, key missense variants (e.g., c.629C>T (p.Ala210Val)) severely impair Ca²⁺ uptake in vitro, and disruption of PDZK2-mediated regulation further reduces channel activity (PMID:17645868). In vivo, TRPV6mut/mut mice subjected to cerulein induction exhibit exacerbated pancreatic enzyme release, histologic damage, and fibrosis, mirroring human disease (PMID:31930989).
A three-member Indian family with hereditary pancreatitis harbors a novel TRPV6 frameshift, c.1474_1475del (p.Val492ThrfsTer136), segregating in father, son and daughter and demonstrating autosomal dominant inheritance with incomplete penetrance (PMID:36699452).
Collectively, genetic, functional and animal data support a Strong clinical validity for TRPV6 in pancreatitis via a loss-of-function mechanism disrupting pancreatic Ca²⁺ homeostasis. Incorporating TRPV6 into routine NGS panels will enhance diagnosis and inform management of early-onset and idiopathic chronic pancreatitis.
Gene–Disease AssociationStrong43 probands with functional TRPV6 variants across Japanese, early-onset and European cohorts (PMID:31930989); family segregation in three members (PMID:36699452); concordant functional and in vivo data (PMID:31930989) Genetic EvidenceStrong43 unrelated probands with heterozygous TRPV6 variants affecting channel function (PMID:31930989); segregation in a family with three affected members (PMID:36699452) Functional EvidenceModerateCerulein-induced pancreatitis in TRPV6mut/mut mice recapitulates human phenotype (PMID:31930989); in vitro assays demonstrate impaired calcium uptake for key TRPV6 variants (PMID:31930989); PDZK2 interaction underpins regulatory mechanism (PMID:17645868) |